Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicitiesSindhu R Johnson, Ralph Brinks, Karen H Costenbader, David Daikh, Marta Mosca, Rosalind Ramsey-Goldman, Josef S Smolen, David Wofsy, Dimitrios T Boumpas, Diane L Kamen, David Jayne, R Cervera, Nathalie Costedoat-Chalumeau, Betty Diamond, Dafna D GladmanSee the full list of authors
14 September 2020
Lack of EULAR/ERA-EDTA response at 1 year predicts poor long-term renal outcome in patients with lupus nephritisGabriella Moroni, Mariele Gatto, Francesco Tamborini, Silvana Quaglini, Francesca Radice, Francesca Saccon, Giulia Frontini, Federico Alberici, Lucia Sacchi, Valentina Binda, Barbara Trezzi, Augusto Vaglio, Piergiorgio Messa, Renato Alberto Sinico, Andrea Doria
13 July 2020
Long-term outcome of a randomised controlled trial comparing tacrolimus with mycophenolate mofetil as induction therapy for active lupus nephritisChi Chiu Mok, Ling Yin Ho, Shirley King Yee Ying, Man Chi Leung, Chi Hung To, Woon Leung Ng
13 July 2020
Remission in systemic lupus erythematosus: testing different definitions in a large multicentre cohortFrancesca Saccon, Margherita Zen, Mariele Gatto, Domenico Paolo Emanuele Margiotta, Antonella Afeltra, Fulvia Ceccarelli, Fabrizio Conti, Alessandra Bortoluzzi, Marcello Govoni, Giulia Frontini, Gabriella Moroni, Francesca Dall'Ara, Angela Tincani, Viola Signorini, Marta MoscaSee the full list of authors
14 June 2020
Impact of the new American College of Cardiology/American Heart Association definition of hypertension on atherosclerotic vascular events in systemic lupus erythematosusKonstantinos Tselios, Dafna D Gladman, Jiandong Su, Murray Urowitz
15 April 2020
Withdrawal of low-dose prednisone in SLE patients with a clinically quiescent disease for more than 1 year: a randomised clinical trialAlexis Mathian, Micheline Pha, Julien Haroche, Fleur Cohen-Aubart, Miguel Hié, Marc Pineton de Chambrun, Thi Huong Du Boutin, Makoto Miyara, Guy Gorochov, Hans Yssel, Patrick Cherin, Hervé Devilliers, Zahir Amoura
12 February 2020
High genetic risk score is associated with early disease onset, damage accrual and decreased survival in systemic lupus erythematosusSarah Reid, Andrei Alexsson, Martina Frodlund, David Morris, Johanna K Sandling, Karin Bolin, Elisabet Svenungsson, Andreas Jönsen, Christine Bengtsson, Iva Gunnarsson, Vera Illescas Rodriguez, Anders Bengtsson, Sabine Arve, Solbritt Rantapää-Dahlqvist, Maija-Leena ElorantaSee the full list of authors
12 February 2020
IFN-α kinoid in systemic lupus erythematosus: results from a phase IIb, randomised, placebo-controlled studyFrederic A Houssiau, Aikaterini Thanou, Minodora Mazur, Edgar Ramiterre, Danny Alexis Gomez Mora, Maria Misterska-Skora, Risto Alfredo Perich-Campos, Svetlana A Smakotina, Sergio Cerpa Cruz, Bassem Louzir, Thérèse Croughs, Michael Lucas Tee
12 February 2020
Neuropsychiatric events in systemic lupus erythematosus: a longitudinal analysis of outcomes in an international inception cohort using a multistate model approachJohn G Hanly, Murray B Urowitz, Caroline Gordon, Sang-Cheol Bae, Juanita Romero-Diaz, Jorge Sanchez-Guerrero, Sasha Bernatsky, Ann E Clarke, Daniel J Wallace, David A Isenberg, Anisur Rahman, Joan T Merrill, Paul R Fortin, Dafna D Gladman, Ian N BruceSee the full list of authors
12 February 2020
In an early SLE cohort the ACR-1997, SLICC-2012 and EULAR/ACR-2019 criteria classify non-overlapping groups of patients: use of all three criteria ensures optimal capture for clinical studies while their modification earlier classification and treatmentChristina Adamichou, Dionysis Nikolopoulos, Irini Genitsaridi, Alessandra Bortoluzzi, Antonis Fanouriakis, Emmanouil Papastefanakis, Eleni Kalogiannaki, Irini Gergianaki, Prodromos Sidiropoulos, Dimitrios T Boumpas, George K Bertsias
27 January 2020
